Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects.
暂无分享,去创建一个
G. Karanikas | C. Bieglmayer | G. Zettinig | B. Niederle | C. Pirich | R. Dudczak | K. Kaserer | Abbas Moameni | C. Poetzi
[1] C. Bieglmayer,et al. Screening for medullary thyroid carcinoma: experience with different immunoassays for human calcitonin. , 2002, Wiener klinische Wochenschrift.
[2] C. Bieglmayer,et al. Interference causes false high calcitonin levels with a commercial assay , 2002, Journal of endocrinological investigation.
[3] O. Haas,et al. Sporadic Versus Familial Medullary Thyroid Microcarcinoma: A Histopathologic Study of 50 Consecutive Patients , 2001, The American journal of surgical pathology.
[4] M. Mannelli,et al. False serum calcitonin high levels using a non-competitive two-site IRMA , 2001, Journal of endocrinological investigation.
[5] A. Remaley,et al. A case of spurious hypercalcitoninemia: A cautionary tale on the use of plasma calcitonin assays in the screening of patients with thyroid nodules for neoplasia , 2001, Journal of endocrinological investigation.
[6] A. Kaider,et al. Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests. , 1999, Surgery.
[7] H. Vierhapper,et al. Basal calcitonin levels and the response to pentagastrin stimulation in patients after kidney transplantation or on chronic hemodialysis as indicators of medullary carcinoma. , 1999, Thyroid : official journal of the American Thyroid Association.
[8] O. Haas,et al. C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin. , 1998, The American journal of surgical pathology.
[9] C. Bieglmayer,et al. Routine measurement of plasma calcitonin in nodular thyroid diseases. , 1997, The Journal of clinical endocrinology and metabolism.
[10] P. Caron,et al. Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. The French Medullary Study Group. , 1997, The Journal of clinical endocrinology and metabolism.
[11] K. Becker,et al. Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization. , 1997, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.
[12] O. Haas,et al. Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto‐oncogene , 1996, International journal of cancer.
[13] K. Molberg,et al. Physiologic versus neoplastic C‐cell hyperplasia of the thyroid: Separation of distinct histologic and biologic entities , 1996, Cancer.
[14] D. Marsh,et al. The identification of false positive responses to the pentagastrin stimulation test in RET mutation negative members of MEN 2A families , 1996, Clinical endocrinology.
[15] D. Marsh,et al. Medullary thyroid carcinoma: recent advances and management update. , 1995, Thyroid : official journal of the American Thyroid Association.
[16] M. Rieu,et al. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules , 1995, Clinical endocrinology.
[17] B. Franc,et al. C-cell hyperplasia associated with chronic lymphocytic thyroiditis: a retrospective quantitative study of 112 cases. , 1994, Human pathology.
[18] A. Pinchera,et al. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. , 1994, The Journal of clinical endocrinology and metabolism.
[19] B. Alford,et al. Clinical review 44: Medullary thyroid carcinoma: recent progress. , 1993, The Journal of clinical endocrinology and metabolism.
[20] J. Albores–Saavedra. C-cell hyperplasia. , 1989, The American journal of surgical pathology.
[21] D. Bellet,et al. A sensitive and specific two-site enzyme-immunoassay for human calcitonin using monoclonal antibodies. , 1988, The Journal of endocrinology.
[22] L. Weiss,et al. Medullary carcinoma arising in a thyroid with Hashimoto's disease. , 1983, American journal of clinical pathology.
[23] B. Croker,et al. Age-associated C-cell hyperplasia in the human thyroid. , 1982, The American journal of pathology.
[24] H. Harach. Sporadic versus familial medullary thyroid microcarcinoma. , 2003, The American journal of surgical pathology.
[25] R. Görges,et al. Sensitive calcitonin measurement by two-site immunometric assays: implications for calcitonin screening in nodular thyroid disease. , 2002, Clinical laboratory.
[26] D. Chappard,et al. Sex-related C cell hyperplasia in the normal human thyroid: a quantitative autopsy study. , 1997, The Journal of clinical endocrinology and metabolism.
[27] A. Mauriello,et al. A Critical Reassessment of the Concept of C-Cell Hyperplasia of the Thyroid: A Quantitative Immunohistochemical Study , 1997 .
[28] V. Rohmer,et al. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma. , 1994, The Journal of clinical endocrinology and metabolism.
[29] R. Perdrisot,et al. Thyroïdite chronique auto-immune et hyperplasie des cellules C. Etude de la sécrétion de calcitonine chez 24 patients. , 1991 .
[30] R. Perdrisot,et al. [Chronic autoimmune thyroiditis and C-cell hyperplasia. Study of calcitonin secretion in 24 patients]. , 1991, Annales d'endocrinologie.
[31] J. Tucci,et al. C-cell hyperplasia of the thyroid in a patient with goitrous hypothyroidism and Hashimoto's thyroiditis. , 1989, The American journal of surgical pathology.
[32] Ja Wilson,et al. Principles and practice of screening for disease , 1968 .